Literature DB >> 8184654

Expression of casein kinase 2 during mouse embryogenesis.

P Mestres1, B Boldyreff, C Ebensperger, H Hameister, O G Issinger.   

Abstract

This paper deals with the expression and distribution of casein kinase 2 (CK-2) subunits in mouse embryos at different developmental stages. Expression was investigated at the mRNA level of CK-2 alpha- and beta-subunits by in situ hybridization and distribution at the protein level by immunohistochemistry using CK-2-alpha- and CK-2-beta-specific antibodies, respectively. In general both methods gave similar results. In earlier stages of mouse embryonic development (day 10.5 after coitus) CK-2 was more expressed in neuroepithelia than in all other tissues. From day 11.5 after coitus on, high expression of CK-2 was detected in all epithelia. From day 16.5 on, all tissues and anlagen of the fetus involved in organogenesis revealed a higher CK-2 expression as compared with secondary mesenchyma. The only difference between in situ hybridization and immunocytochemistry was observed in the skin. Transcripts of CK-2 were found mostly in the basal layer of the epidermis and in the nuclei of keratinocytes, whereas CK-2 protein was almost exclusively found in the cytoplasm of epidermal cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8184654     DOI: 10.1159/000147550

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  8 in total

1.  Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.

Authors:  Nadine Wilhelm; Katja Kostelnik; Claudia Götz; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2012-01-24       Impact factor: 3.396

Review 2.  Murine protein kinase CK2: gene and oncogene.

Authors:  X Xu; E Landesman-Bollag; P L Channavajhala; D C Seldin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  CK2α is essential for embryonic morphogenesis.

Authors:  Isabel Dominguez; Irene R Degano; Kathleen Chea; Julie Cha; Paul Toselli; David C Seldin
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

4.  Protein kinase CK2 in development and differentiation.

Authors:  Claudia Götz; Mathias Montenarh
Journal:  Biomed Rep       Date:  2016-12-19

5.  CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.

Authors:  Michelle E Ernst; Evan H Baugh; Amanda Thomas; Louise Bier; Natalie Lippa; Nicholas Stong; Maureen S Mulhern; Sulagna Kushary; Cigdem I Akman; Erin L Heinzen; Raymond Yeh; Weimin Bi; Neil A Hanchard; Lindsay C Burrage; Magalie S Leduc; Josephine S C Chong; Renee Bend; Michael J Lyons; Jennifer A Lee; Pim Suwannarat; Eva Brilstra; Marleen Simon; Marije Koopmans; Ellen van Binsbergen; Daniel Groepper; Julie Fleischer; Caroline Nava; Boris Keren; Cyril Mignot; Sophie Mathieu; Grazia M S Mancini; Suneeta Madan-Khetarpal; Elena M Infante; Judith Bluvstein; Andrea Seeley; Kristine Bachman; Eric W Klee; Laura E Schultz-Rogers; Linda Hasadsri; Sarah Barnett; Marissa S Ellingson; Matthew J Ferber; Vinodh Narayanan; Keri Ramsey; Anita Rauch; Pascal Joset; Katharina Steindl; Theodore Sheehan; Annapurna Poduri; Alejandra Vasquez; Claudia Ruivenkamp; Susan M White; Lynn Pais; Kristin G Monaghan; David B Goldstein; Tristan T Sands; Vimla Aggarwal
Journal:  Epilepsia       Date:  2021-05-26       Impact factor: 6.740

6.  Inhibition of Protein Kinase CK2 Prevents Adipogenic Differentiation of Mesenchymal Stem Cells Like C3H/10T1/2 Cells.

Authors:  Lisa Schwind; Sarah Schetting; Mathias Montenarh
Journal:  Pharmaceuticals (Basel)       Date:  2017-02-09

7.  De Novo CSNK2B Mutations in Five Cases of Poirier-Bienvenu Neurodevelopmental Syndrome.

Authors:  Qi Yang; Qinle Zhang; Shang Yi; Zailong Qin; Fei Shen; Shang Ou; Jingsi Luo; Sheng He
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

8.  Multisite dependency of an E3 ligase controls monoubiquitylation-dependent cell fate decisions.

Authors:  Achim Werner; Regina Baur; Nia Teerikorpi; Deniz U Kaya; Michael Rape
Journal:  Elife       Date:  2018-07-12       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.